San Francisco, CA, United States of America

James E Lindauer

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2012-2017.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of James E Lindauer

Introduction

James E Lindauer is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medical technology, particularly in ECG monitoring systems. With a total of 2 patents, his work has the potential to enhance patient care and diagnostic accuracy.

Latest Patents

One of his latest patents is the QT interval monitoring system with alarms and trending. This ECG monitoring system continuously monitors a patient's ECG waveform and periodically identifies the patient's QT interval. QT interval values are averaged over time, producing a corrected interval value QTc and a change in QTc relative to a baseline, dQTc. An alarm is responsive to updated QT interval values and issues an alert whenever a selected QT value exceeds an alarm limit. The periodically produced QT interval values are stored, and a trend display may be produced showing changes in the QT interval information over different periods of time. The trend display may selectively display the trend information either graphically or in tabular form.

Another significant patent is the automated identification of the culprit coronary artery. This diagnostic ECG system analyzes lead traces for evidence of ST elevation in the lead signals. The pattern of ST elevation in leads having predetermined vantage points to the electrical activity of the heart, and in some instances, the presence of ST depression in certain other leads, identifies a specific coronary artery or branch as the culprit coronary artery for an acute ischemic event. The identity of the culprit coronary artery or branch is presented to the interventional cardiologist so that the correct coronary artery is accessed and the obstruction cleared. This technique can be used with standard 12-lead ECG systems as well as with ECG systems using fewer or more leads.

Career Highlights

James has worked with prominent companies such as Koninklijke Philips Corporation N.V. and Philips Intellectual Property & Standards GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in medical technology.

Collaborations

James has collaborated with notable professionals in his field, including Richard Earl Gregg and Eric Helfenbein. Their combined expertise has contributed to the advancement of medical diagnostic technologies.

Conclusion

James E Lindauer's contributions to ECG monitoring and diagnostic systems demonstrate his commitment to improving healthcare technology. His innovative patents reflect a deep understanding of medical needs and a dedication to enhancing patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…